Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese HSK 1 – For Medical Students & Physicians A complete 20-lesson, 300-page Chinese HSK 1 course with a companion app in 21 languages — free forever. Arabic, Bengali, Dutch, English, Farsi, French, German, Hindi, Indonesian, Italian, Japanese, Korean, Portuguese, Russian, Spanish, Tagalog, Thai, Turkish, Ukrainian, Urdu, Vietnamese. By Bernd Sebastian Kamps and Andrea Melis

Alzheimer's Disease

Free Subscription Articles published in Drugs Retrieve available abstracts of 10 articles: HTML format

Single Articles

September 2025
1. ABUSHAKRA S, Power A, Watson D, Porsteinsson A, et al
   Clinical Efficacy, Safety and Imaging Effects of Oral Valiltramiprosate in APOEepsilon4/epsilon4 Homozygotes with Early Alzheimer's Disease: Results of the Phase III, Randomized, Double-Blind, Placebo-Controlled, 78-Week APOLLOE4 Trial.
   Drugs. 2025 Sep 28. doi: 10.1007/s40265-025-02250.
   PubMed     Abstract available
   
   
   
2. SMOLLER C, Schiller E, Yamashita K, Silverglate BD, et al
   Current and Emerging Pharmacological Approaches to Agitation in Alzheimer's Disease: A Narrative Review of New and Repurposed Therapies.
   Drugs. 2025 Sep 6. doi: 10.1007/s40265-025-02227.
   PubMed     Abstract available
   
   
   January 2025
3. SYED YY
   Xanomeline/Trospium Chloride: First Approval.
   Drugs. 2025;85:103-109.
   PubMed     Abstract available
   
   
   October 2024
4. CARPI M, Mercuri NB, Liguori C
   Orexin Receptor Antagonists for the Prevention and Treatment of Alzheimer's Disease and Associated Sleep Disorders.
   Drugs. 2024 Oct 4. doi: 10.1007/s40265-024-02096.
   PubMed     Abstract available
   
   
   
5. KANG C
   Donanemab: First Approval.
   Drugs. 2024;84:1313-1318.
   PubMed     Abstract available
   
   
   June 2024
6. HEY JA, Yu JY, Abushakra S, Schaefer JF, et al
   Analysis of Cerebrospinal Fluid, Plasma beta-Amyloid Biomarkers, and Cognition from a 2-Year Phase 2 Trial Evaluating Oral ALZ-801/Valiltramiprosate in APOE4 Carriers with Early Alzheimer's Disease Using Quantitative Systems Pharmacology Model.
   Drugs. 2024 Jun 20. doi: 10.1007/s40265-024-02068.
   PubMed     Abstract available
   
   
   
7. HEY JA, Abushakra S, Blennow K, Reiman EM, et al
   Effects of Oral ALZ-801/Valiltramiprosate on Plasma Biomarkers, Brain Hippocampal Volume, and Cognition: Results of 2-Year Single-Arm, Open-Label, Phase 2 Trial in APOE4 Carriers with Early Alzheimer's Disease.
   Drugs. 2024 Jun 20. doi: 10.1007/s40265-024-02067.
   PubMed     Abstract available
   
   
   September 2023
8. CUMMINGS JL, Osse AML, Kinney JW
   Alzheimer's Disease: Novel Targets and Investigational Drugs for Disease Modification.
   Drugs. 2023 Sep 20. doi: 10.1007/s40265-023-01938.
   PubMed     Abstract available
   
   
   April 2023
9. CUMMINGS J
   Anti-Amyloid Monoclonal Antibodies are Transformative Treatments that Redefine Alzheimer's Disease Therapeutics.
   Drugs. 2023 Apr 15. doi: 10.1007/s40265-023-01858.
   PubMed     Abstract available
   
   
   March 2023
10. HOY SM
    Lecanemab: First Approval.
    Drugs. 2023;83:359-365.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Alzheimer's Disease is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum